Trailing-twelve-month (TTM) revenue is $15.05 Billion with a year-over-year growth of +5.08%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-30 | $3,481,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q2 FY2026Period ended 2025-12-31 | $4,238,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q3 FY2026Period ended 2026-03-31 | $3,712,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-01 |
| Q4 FY2026Period ended 2026-06-30 | $3,618,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-19 |
| TTM revenue | $15,049,000,000 |
Current P/S: $33,791,261,802 market capitalization ÷ $15,049,000,000 TTM revenue = 2.25x.
Market capitalization source: FMP quote. Quote observed 2026-09-18T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-06-30): $3.62B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-19T00:15:36.677Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|---|---|
| Fragrance | $1.9B | $2.5B | $2.5B | $2.5B | $2.5B | $2.8B |
| Hair Care | $571M | $631M | $653M | $629M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $5.5B | $5.4B | $5.2B | $4.9B | $4.5B | $3.7B |
| E M E A | $6.9B | $7.7B | $6.2B | $6.1B |
$15.05B
$15.05 Billion
+5.08%
vs. $14.32B a year ago (TTM)
(1.48%)
5 Year compound annual growth rate
1 Year
+5.08%
3 Year
(1.84%)
5 Year
(1.48%)
10 Year
+2.94%
15 Year
+3.63%
20 Year
+4.32%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $15.05B | +$761.00M | +5.33% |
| 2025 | $14.29B | ($1.32B) | (8.46%) |
| 2024 | $15.61B | ($302.00M) | (1.90%) |
| 2023 | $15.91B | ($1.83B) | (10.30%) |
| 2022 | $17.74B | +$1.52B | +9.39% |
| 2021 |
TTM Growth
+5.08%
3-Year CAGR
(1.84%)
5-Year CAGR
(1.48%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-19T00:15:36.677Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $565M |
| $565M |
| Makeup | $4.2B | $4.7B | $4.5B | $4.5B | $4.2B | $4.3B |
|---|
| Skin Care | $9.5B | $9.9B | $8.2B | $7.9B | $7.0B | $7.3B |
|---|
| N/A |
| UNITED STATES | $3.8B | $4.6B | $4.5B | $4.6B | $4.4B | $4.5B |
|---|
| $16.21B |
| +$1.92B |
| +13.44% |
| 2020 | $14.29B | ($569.00M) | (3.83%) |
| 2019 | $14.86B | +$1.18B | +8.62% |
| 2018 | $13.68B | +$1.86B | +15.72% |
| 2017 | $11.82B | +$561.70M | +4.99% |
